Energy Drinks Tied to Negative Sleep Outcomes in College Students
23 Jan 2024
Clinical Result
TUESDAY, Jan. 23, 2024 -- Energy drink consumption is strongly associated with negative sleep outcomes in both male and female college students, according to a study published online Jan. 22 in BMJ Open.
Siri Kaldenbach, from Innlandet Hospital Trust in Lillehammer, Norway, and colleagues examined the frequency of energy drink consumption and its association with selected sleep characteristics and parameters in Norwegian college and university students. The analysis included 53,266 students (aged 18 to 35 years) participating in the 2022 Students' Health and Well-being Study.
The researchers found that 4.7 percent of men and 3.3 percent of women reported consuming energy drinks daily. Consumption frequency was inversely associated with sleep duration and efficiency. Across sexes, there was a direct association between the frequency of energy drink consumption and sleep patterns, such as sleep-onset latency and wake after sleep onset. Daily energy drink consumption was associated with short sleep duration (risk ratios, 2.07 and 1.87 for men and women, respectively).
"Energy drink consumption was a strong determinant for negative sleep outcomes," the authors write. "Even small amounts of energy drinks were associated with poorer sleep outcomes, which warrant more attention towards the consequences of consuming energy drinks among college and university students."
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.